These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30571186)

  • 41. GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation.
    Otvos JD; Shalaurova I; Wolak-Dinsmore J; Connelly MA; Mackey RH; Stein JH; Tracy RP
    Clin Chem; 2015 May; 61(5):714-23. PubMed ID: 25779987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile.
    Mokkala K; Houttu N; Koivuniemi E; Sørensen N; Nielsen HB; Laitinen K
    Metabolomics; 2020 Jun; 16(7):76. PubMed ID: 32564244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of
    Fuertes-Martín R; Taverner D; Vallvé JC; Paredes S; Masana L; Correig Blanchar X; Amigó Grau N
    J Proteome Res; 2018 Nov; 17(11):3730-3739. PubMed ID: 30353728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.
    Dungan K; Binkley P; Osei K
    Inflammation; 2015; 38(3):1357-63. PubMed ID: 25586483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased glycoprotein acetylation is associated with high cardiac event rates: Analysis using coronary computed tomography angiography.
    An L; Liu Q; Feng H; Bai X; Dang Y; Li C; Yang Z; Li J
    Anatol J Cardiol; 2018 Sep; 20(3):152-158. PubMed ID: 30152796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
    Sun J; Axelsson J; Machowska A; Heimbürger O; Bárány P; Lindholm B; Lindström K; Stenvinkel P; Qureshi AR
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1163-1172. PubMed ID: 27281698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population-Based, Prospective Study and Mendelian Randomization Analysis.
    Joshi AD; McCormick N; Yokose C; Yu B; Tin A; Terkeltaub R; Merriman TR; Eliassen AH; Curhan GC; Raffield LM; Choi HK
    Arthritis Rheumatol; 2023 Sep; 75(9):1648-1657. PubMed ID: 37043280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes.
    Llauradó G; Amigó N; Fuertes-Martín R; Romero A; Cano A; Albert L; Giménez-Palop O; Berlanga E; Fernández-Veledo S; Correig X; Vendrell J; González-Clemente JM
    Diabetes Care; 2022 Oct; 45(10):2430-2438. PubMed ID: 35984043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammation and hearing status in mid-childhood and mid-life: a population-based cross-sectional study.
    Wang J; Sung V; Carew P; Liu RS; Burgner D; Wake M
    Int J Epidemiol; 2019 Oct; 48(5):1556-1566. PubMed ID: 30815675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multimarkers of metabolic malnutrition and inflammation and their association with mortality risk in cardiac catheterisation patients: a prospective, longitudinal, observational, cohort study.
    Otvos JD; Shalaurova I; May HT; Muhlestein JB; Wilkins JT; McGarrah RW; Kraus WE
    Lancet Healthy Longev; 2023 Feb; 4(2):e72-e82. PubMed ID: 36738747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Landman GW; Kleefstra N; Groenier KH; Bakker SJ; Groeneveld GH; Bilo HJ; van Hateren KJ
    Atherosclerosis; 2016 Jul; 250():46-51. PubMed ID: 27179179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
    Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of hepato-preferential basal insulin peglispro on nuclear magnetic resonance biomarkers lipoprotein insulin resistance index and GlycA in patients with diabetes.
    Connelly MA; Otvos JD; Zhang Q; Zhang S; Antalis CJ; Chang AM; Hoogwerf BJ
    Biomark Med; 2017 Nov; 11(11):991-1001. PubMed ID: 29160108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus.
    Chung CP; Ormseth MJ; Connelly MA; Oeser A; Solus JF; Otvos JD; Raggi P; Stein CM
    Lupus; 2016 Mar; 25(3):296-300. PubMed ID: 26637290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of the Composite Inflammatory Biomarker GlycA, with Exercise-Induced Changes in Body Habitus in Men and Women with Prediabetes.
    Bartlett DB; Slentz CA; Connelly MA; Piner LW; Willis LH; Bateman LA; Granville EO; Bales CW; Huffman KM; Kraus WE
    Oxid Med Cell Longev; 2017; 2017():5608287. PubMed ID: 28642810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kidney Dysfunction Increases Mortality and Incident Events after Young Stroke: The FUTURE Study.
    Synhaeve NE; van Alebeek ME; Arntz RM; Maaijwee NA; Rutten-Jacobs LC; Schoonderwaldt HC; de Kort PL; van der Vlugt MJ; Van Dijk EJ; Wetzels JF; de Leeuw FE
    Cerebrovasc Dis; 2016; 42(3-4):224-31. PubMed ID: 27173119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
    Peeters SA; Engelen L; Buijs J; Jorsal A; Parving HH; Tarnow L; Rossing P; Schalkwijk CG; Stehouwer CDA
    Cardiovasc Diabetol; 2017 Apr; 16(1):55. PubMed ID: 28446168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.